Endophenotypes of Traumatic Brain Injury: What to Know For the Next Generation of Clinical Trials

Dr. Diaz-Arrastia of the University of Pennsylvania describes the history and current prevalance of Traumatic Brain Injury (TBI) and understanding of 2 specific endophenotypes including diffuse axonal injury and serum Nf-L as biomarkers that may help with TBI diagnosis and treament monitoring at the 2019 Powering Precision Health Summit in Barcelona, Spain.